The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...

Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...

The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

Whooping cough cases are rising, and doctors are bracing for yet another tough year. There have been 8,485 cases reported in ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

MAJOR drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they grapple with the threat of sector-specific tariffs, efforts to lower drug ...

EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions.